Intellia Therapeutics
Kim Price is a seasoned professional in medical communications and education, currently serving as Senior Director of Medical Communications at Intellia Therapeutics, Inc. since April 2025. Prior roles include Senior Director of Medical Education and Training at Sage Therapeutics and various positions at bluebird bio, including US Medical Director. Kim's experience spans several leadership roles in medical communications and training at ARIAD Pharmaceuticals and Biogen Idec, along with an academic position as Adjunct Professor at MCPHS University. Kim holds a Doctor of Pharmacy (Pharm.D.) from the Massachusetts College of Pharmacy and Health Sciences and previously studied at the University of Arizona.
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.